 |
|  |
Jun-05-19 | Upgrade |
Wells Fargo |
Market Perform → Outperform |
|
|
Feb-04-19 | Reiterated |
Needham |
Strong Buy |
$120 → $117 |
|
Jan-03-19 | Initiated |
Deutsche Bank |
Buy |
$99 |
|
Jan-02-19 | Downgrade |
Citigroup |
Buy → Neutral |
|
|
Dec-19-18 | Upgrade |
JP Morgan |
Neutral → Overweight |
|
|
Nov-28-18 | Initiated |
UBS |
Buy |
|
|
Oct-16-18 | Initiated |
Barclays |
Overweight |
$113 |
|
Aug-27-18 | Reiterated |
Argus |
Buy |
$95 → $108 |
|
Aug-22-18 | Reiterated |
Stifel |
Hold |
$87 → $96 |
|
Aug-13-18 | Upgrade |
Needham |
Buy → Strong Buy |
$103 → $119 |
|
Jun-27-18 | Initiated |
Bernstein |
Mkt Perform |
$88 |
|
Jun-06-18 | Resumed |
William Blair |
Mkt Perform |
|
|
Jun-06-18 | Reiterated |
Needham |
Buy |
$97 → $103 |
|
May-31-18 | Initiated |
Raymond James |
Outperform |
$96 |
|
Apr-27-18 | Resumed |
Piper Jaffray |
Overweight |
$90 |
|
Feb-22-18 | Reiterated |
Citigroup |
Buy |
$100 → $93 |
|
Jan-03-18 | Initiated |
Evercore ISI |
Outperform |
$92.50 |
|
Jan-02-18 | Upgrade |
BofA/Merrill |
Neutral → Buy |
|
|
Dec-12-17 | Upgrade |
Argus |
Hold → Buy |
|
|
Nov-22-17 | Reiterated |
Stifel |
Hold |
$83 → $85 |
|
|
 |
Dec-06-19 04:01PM | ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock PR Newswire |
02:46PM | No more finger prick? Md. biotech aims for bigger market for diabetes app. American City Business Journals |
09:20AM | Zacks.com featured highlights include: Target, Medtronic Public, Arconic, Science Applications International and Bristol-Myers Squibb Zacks |
06:45AM | Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2020 GlobeNewswire |
Dec-04-19 09:11AM | 5 High-Flying Stocks Near 52-Week High With More Room to Run Zacks |
05:00AM | Money in Medicine: These drug and device companies paid the most to D.C. doctors in 2018 American City Business Journals |
12:15AM | ViewRay Announces Pricing of Public Offering of Common Stock PR Newswire |
Dec-03-19 09:47AM | The Zacks Analyst Blog Highlights: Medtronic, Apple, Stryker and Intuitive Surgical Zacks |
Dec-02-19 04:01PM | ViewRay Announces Collaborations with Elekta and Medtronic PR Newswire |
10:53AM | Industry 4.0 to Steer MedTech to Higher Growth: A Sneak Peek Zacks |
Nov-29-19 04:16PM | Urbem's 'Wonderful Business' Series: Intuitive Surgical GuruFocus.com |
09:56AM | Medtronic Displays All-Business-Line Growth Despite Cost Woes Zacks |
Nov-28-19 08:14AM | Digital Diabetes Management Gains Momentum: 3 Stocks in Focus Zacks |
Nov-26-19 11:31AM | Medtronic Gets FDA Nod for IN.PACT AV for ESRD Patients Zacks |
09:13AM | Is Medtronic plc (MDT) A Good Stock To Buy ? Insider Monkey |
Nov-25-19 08:42AM | Here's Why You Should Hold on to Varian (VAR) Stock for Now Zacks |
Nov-24-19 08:03PM | Here is 16th Most Popular Stock Among 752 Hedge Funds Insider Monkey |
Nov-22-19 08:08AM | Earnings Beat: Medtronic plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St. |
Nov-21-19 02:50PM | Earnings Reports for the Week of Nov. 18-22 (ANF, BBY, PANW) Kiplinger |
11:05AM | Medtronic Drug-Coated Balloon Receives U.S. FDA Approval to Treat Arteriovenous Fistula Lesions GlobeNewswire |
Nov-19-19 05:57PM | Edited Transcript of MDT earnings conference call or presentation 19-Nov-19 1:00pm GMT Thomson Reuters StreetEvents |
04:21PM | Will This Medtech Giant Edge Into Another Breakout On Its Earnings Beat? Investor's Business Daily |
04:16PM | Nasdaq closes at new high; Dow, S&P retreat from records on earnings and doubts about China trade deal MarketWatch |
10:11AM | Medtronic (MDT) Beats on Q2 Earnings, Ups FY20 EPS Guidance Zacks |
09:26AM | Zacks.com featured highlights include: Medtronic Public, Arconic, Nasdaq, Hewlett Packard and Target Zacks |
08:05AM | Medtronic (MDT) Tops Q2 Earnings and Revenue Estimates Zacks |
07:18AM | UPDATE 1-Medtronic Plc beats profit estimates, raises 2020 forecast again Reuters |
07:07AM | Medtronic's stock surges after earnings rise above expectations, and outlook raised MarketWatch |
06:54AM | Medical device maker Medtronic's quarterly profit rises 22% Reuters |
06:45AM | Medtronic Reports Second Quarter Financial Results GlobeNewswire |
05:08AM | Medtronic Wavers After Posting Earnings Beat; Cardiac Unit Misses Estimates TheStreet.com |
01:47AM | Medtronic Earnings, Revenue Beat in Q2 Investing.com |
Nov-18-19 10:17AM | Medtronic (MDT) to Report Q2 Earnings: What's in Store? Zacks |
09:18AM | 5 Stocks Trading Near 52-Week High With More Room to Run Zacks |
06:34AM | Medtronic Set to Trade Higher Unless Earnings Derail the Rally TheStreet.com |
Nov-17-19 03:50PM | Barron's Picks And Pans: Medtronic, Tesla, Walmart And More Benzinga |
Nov-16-19 03:54PM | UPDATE 1-Stents no better than drugs for many heart patients -U.S. study Reuters |
02:00PM | Stents no better than drugs for many heart patients -U.S. study Reuters |
Nov-15-19 09:15PM | Medtronic Stock Could Rise Even More on Plans to Sell a Lot More Pacemakers Barrons.com |
Nov-14-19 02:00PM | Medtronic Highlights Leadership in Inclusion, Diversity, and Equity in 2019 Integrated Performance Report GlobeNewswire |
Nov-13-19 09:56AM | Here's Why You Should Add NuVasive (NUVA) to Your Portfolio Zacks |
Nov-12-19 10:30AM | Medtronic (MDT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks |
08:19AM | Medtronic (MDT) Releases Positive Study Results on Pacemaker Zacks |
Nov-11-19 05:45PM | Medtronic (MDT) Gains As Market Dips: What You Should Know Zacks |
09:00AM | New Study Shows Promise in Treating More Patients with Worlds Smallest Pacemaker GlobeNewswire |
Nov-08-19 08:06AM | Is Medtronic plc (NYSE:MDT) An Attractive Dividend Stock? Simply Wall St. |
Nov-07-19 07:54AM | Memphis biotech conference unites investors, startups, major players American City Business Journals |
07:00AM | Minnesota business execs place the most and biggest bets on Klobuchar for president American City Business Journals |
Nov-06-19 06:26PM | Global Investment Presents Opportunity Investopedia |
Nov-05-19 05:45PM | Medtronic (MDT) Dips More Than Broader Markets: What You Should Know Zacks |
01:15PM | Four-Year Data from the IN.PACT Global Study Highlight Durable Performance and Safety of IN.PACT Admiral DCB GlobeNewswire |
10:00AM | Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2020 GlobeNewswire |
Nov-04-19 04:33PM | Analysts Bullish on Axonics' Prospects GuruFocus.com |
Nov-01-19 11:40AM | American Century Equity Income Focuses on Value Kiplinger |
Oct-31-19 11:45AM | United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up Zacks |
11:15AM | Medtronic Introduces Robotics Challenger to Intuitive System GuruFocus.com |
10:00AM | Medtronic Announces Shonin Approval and Launch of the Valiant Navion Thoracic Stent Graft System in Japan GlobeNewswire |
Oct-30-19 05:45PM | Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know Zacks |
02:00PM | Medtronic Launches New Activa Patient Programmer for DBS Therapy GlobeNewswire |
Oct-29-19 05:09PM | This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks Insider Monkey |
12:00PM | Medtronic Receives FDA Breakthrough Device Designation for Developing Fully Implantable Heart Pump GlobeNewswire |
Oct-24-19 05:45PM | Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know Zacks |
09:36AM | Medtronic Operating Toward Renewed Gains TheStreet.com |
Oct-23-19 10:05AM | Could The Medtronic plc (NYSE:MDT) Ownership Structure Tell Us Something Useful? Simply Wall St. |
Oct-22-19 11:44AM | Quest Diagnostics (DGX) Q3 Earnings Surpass, View Strong Zacks |
11:34AM | Zacks.com featured highlights include: Target, Owens Corning, Booz Allen Hamilton, Medtronic and Dick's Sporting Goods Zacks |
09:13AM | Medical Products Industry Outlook: Prospects Seem Promising Zacks |
09:00AM | AMLOs Hugs Not Bullets Is Failing Mexico Bloomberg |
Oct-21-19 08:24AM | 5 Solid Dividend Growth Stocks for Higher Returns Zacks |
06:45AM | Sean Salmon Named Executive Vice President and Group President of Medtronic Diabetes GlobeNewswire |
Oct-18-19 08:52PM | Health-Care Stocks Are Getting Back on Their Feet Barrons.com |
11:13AM | 3 Medical Product Stocks Likely to Beat This Earnings Season Zacks |
09:11AM | Intuitive Surgical (ISRG) Beats on Q3 Earnings, View Solid Zacks |
Oct-17-19 05:45PM | Medtronic Launches the First Artificial Intelligence System for Colonoscopy at United European Gastroenterology Week 2019 GlobeNewswire |
Oct-16-19 05:50PM | Medtronic (MDT) Gains As Market Dips: What You Should Know Zacks |
04:21PM | Here's what 3,000 Medtronic jobs could mean for this Denver suburb American City Business Journals |
12:12PM | Philips Boosts Stellarex Portfolio, Expands in Healthcare Zacks |
11:17AM | Abbott (ABT) Meets Q3 Earnings Estimates, Lowers EPS Guidance Zacks |
10:25AM | Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now Zacks |
09:30AM | Has Medtronic (MDT) Outpaced Other Medical Stocks This Year? Zacks |
08:29AM | Medtronic may build new Colorado campus for 3,000 employees American City Business Journals |
Oct-15-19 10:42AM | Tandem Rides on Strong t:slim X2 Rollout Amid Stiff Rivalry Zacks |
08:48AM | Here's Why You Should Hold on to CONMED (CNMD) Stock for Now Zacks |
08:31AM | QIAGEN (QGEN) Launches QIAseq FastSelect Technology Kits Zacks |
Oct-14-19 11:52AM | Align Rides on Volume Expansion Amid Poor Shipment Scenario Zacks |
08:30AM | Edwards Lifesciences Hits a 52-Week High on Solid Prospects Zacks |
08:17AM | Here's Why You Should Retain Henry Schein (HSIC) Stock Now Zacks |
Oct-10-19 05:45PM | Medtronic (MDT) Gains But Lags Market: What You Should Know Zacks |
10:08AM | Here's Why You Should Add Stryker (SYK) to Your Portfolio Now Zacks |
08:53AM | 4 Stocks From Highest Job-Creating Sectors in September Zacks |
Oct-09-19 06:36PM | Hedge Fund Sentiment in Medtronic plc (MDT) Is Above Average Insider Monkey |
05:10PM | Medtronic Submits Two Pelvic Health Devices for FDA's PMA Zacks |
04:00PM | FDA Classifies Medtronic Sherpa Delivery Catheter Field Action Initiated in March 2019 as Class I Recall GlobeNewswire |
09:23AM | Stratasys Unveils Medical 3D Printer, Boosts Market Foothold Zacks |
07:56AM | Medtronic Gets FDA's Breakthrough Device Nod for Valiant TAAA Zacks |
07:50AM | Here's Why You Should Hold on to Teleflex (TFX) Stock Now Zacks |
Oct-08-19 10:05AM | Axonics (AXNX) Upbeat on Results of Its ARTISAN-SNM Study Zacks |
10:00AM | Medtronic Receives FDA Breakthrough Device Designation for Developing Stent Graft System to Treat Thoracoabdominal Aortic Aneurysm GlobeNewswire |
09:34AM | Did Medtronic plc's (NYSE:MDT) Recent Earnings Growth Beat The Trend? Simply Wall St. |
Oct-07-19 01:00PM | Medtronic Initiates Worldwide Pivotal Study of a New Approach to Treating Dangerously Fast Heart Rhythms GlobeNewswire |
|
|
|
 |
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates in four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland. |
 |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WHITE ROBERT JOHN | EVP & President MITG | Dec 02 | Option Exercise | 61.26 | 52,166 | 3,195,798 | 104,234 | Dec 03 04:25 PM | WHITE ROBERT JOHN | EVP & President MITG | Dec 02 | Sale | 110.62 | 52,166 | 5,770,829 | 52,068 | Dec 03 04:25 PM | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | Nov 15 | Option Exercise | 38.81 | 36,874 | 1,431,080 | 225,136 | Nov 18 05:31 PM | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | Nov 15 | Sale | 111.25 | 36,874 | 4,102,092 | 188,262 | Nov 18 05:31 PM | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | Nov 14 | Option Exercise | 40.41 | 2,102 | 84,932 | 189,464 | Nov 15 05:49 PM | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | Nov 14 | Sale | 109.77 | 2,102 | 230,731 | 188,262 | Nov 15 05:49 PM | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | Nov 01 | Option Exercise | 38.90 | 38,976 | 1,516,012 | 226,036 | Nov 04 06:26 PM | WHITE ROBERT JOHN | EVP & President MITG | Nov 01 | Option Exercise | 36.34 | 52,165 | 1,895,478 | 95,158 | Nov 04 06:28 PM | WHITE ROBERT JOHN | EVP & President MITG | Nov 01 | Sale | 109.33 | 52,165 | 5,702,995 | 52,068 | Nov 04 06:28 PM | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | Nov 01 | Sale | 109.50 | 38,976 | 4,267,872 | 188,262 | Nov 04 06:26 PM | Surface Carol A | SVP, Chief HR Officer | Oct 11 | Option Exercise | 80.85 | 84,207 | 6,808,395 | 121,920 | Oct 15 04:37 PM | WHITE ROBERT JOHN | EVP & President MITG | Oct 01 | Option Exercise | 28.17 | 52,165 | 1,469,549 | 104,082 | Oct 02 04:54 PM | Kuntz Richard | SVP & Chief Medical & Science | Sep 27 | Sale | 107.51 | 21,425 | 2,303,493 | 78,816 | Sep 30 05:52 PM | Lenehan James T | Director | Sep 25 | Option Exercise | 44.13 | 1,813 | 80,008 | 55,464 | Sep 26 06:20 PM | HAKAMI HOOMAN | EVP & Group President Diabetes | Sep 10 | Option Exercise | 85.70 | 72,877 | 6,245,604 | 58,015 | Sep 12 05:55 PM | HAKAMI HOOMAN | EVP & Group President Diabetes | Sep 10 | Sale | 107.31 | 82,877 | 8,893,712 | 30,761 | Sep 12 05:55 PM | Lerman Bradley E | SVP General Counsel & Corp Sec | Aug 05 | Sale | 100.31 | 4,000 | 401,240 | 52,906 | Aug 06 05:53 PM | Lerman Bradley E | SVP General Counsel & Corp Sec | Aug 02 | Sale | 102.02 | 6,599 | 673,230 | 56,906 | Aug 02 06:32 PM | Kuntz Richard | SVP & Chief Medical & Science | Aug 02 | Sale | 102.02 | 5,719 | 583,452 | 100,241 | Aug 02 06:29 PM | Kuntz Richard | SVP & Chief Medical & Science | Jul 22 | Sale | 101.12 | 3,438 | 347,651 | 100,127 | Jul 23 06:03 PM | Surface Carol A | SVP, Chief HR Officer | Jun 17 | Sale | 97.66 | 9,000 | 878,976 | 34,158 | Jun 18 05:31 PM | HAKAMI HOOMAN | EVP & Group President Diabetes | Jun 12 | Option Exercise | 78.00 | 31,731 | 2,475,018 | 95,337 | Jun 14 04:51 PM | HAKAMI HOOMAN | EVP & Group President Diabetes | Jun 12 | Sale | 97.49 | 52,664 | 5,134,213 | 42,673 | Jun 14 04:51 PM | Martha Geoffrey | EVP & GroupPres Restora Therap | Jun 06 | Sale | 96.05 | 11,000 | 1,056,583 | 48,918 | Jun 07 05:34 PM | TEN HOEDT ROB | EVP & President EMEA | May 28 | Sale | 91.88 | 9,000 | 826,920 | 58,785 | May 29 05:37 PM | ANDERSON RICHARD H | Director | May 24 | Buy | 92.40 | 10,900 | 1,007,160 | 89,912 | May 28 07:54 PM | OLEARY DENISE M | Director | Apr 01 | Option Exercise | 29.96 | 2,671 | 80,023 | 62,484 | Apr 02 04:45 PM | Lenehan James T | Director | Mar 04 | Option Exercise | 29.96 | 2,671 | 80,023 | 51,808 | Mar 05 06:36 PM | PARKHILL KAREN L | EVP & Chief Financial Officer | Jan 09 | Buy | 83.87 | 3,000 | 251,610 | 83,680 | Jan 09 12:28 PM | ISHRAK OMAR | Chairman & CEO | Jan 09 | Buy | 84.05 | 12,000 | 1,008,540 | 570,722 | Jan 09 12:27 PM |
|
 |
|
 |
|